Abstract:Objective: To investigate the role of mast cells in atopic dermatitis (AD) phenotype and the immune activation of type 2 inflammatory cytokine release. Methods: Nine AD skin samples were obtained from the Department of Dermatology, the Second Affiliated Hospital of Xi'an Jiaotong University, and nine healthy skin control samples were obtained from the surgical excision of excess normal skin by orthopedic surgery, the Second Affiliated Hospital of Xi'an Jiaotong University, which were subjected to toluidine blue staining and fluorescence staining to clarify the mast cell degranulation activation status of the AD skin lesions. We investigated whether MC903 could directly activate mast cells in vivo through the toe swelling and exudation assay in wild-type mice; we constructed the MC903-AD model using wild-type and KitW-sh/W-sh mast cell-deficient mice in order to investigate whether mast cells affected the phenotype, histopathology, and the level of type 2 inflammatory factors in AD mice; we extracted mouse peritoneal mast cells and the ability of MC903 to activate mast cells to release inflammatory mediators in vitro was explored by calcium imaging, tryptase and β-aminohexokinase release assays, and MCP-1 and CXCL-2 release assays. Results: The number of degranulated mast cells in an activated state was increased in skin lesions of AD patients compared to healthy controls, with (5.40±1.14) and (2.20±0.84), respectively (P<0.001). KitW-sh/W-sh mast cell-deficient AD mice had an attenuated phenotype with ADI scores of (5.50±1.05), compared to wild-type AD mice with (10.00±0.89) (P<0.001). The release of type 2 inflammatory factors in wild-type AD mice was higher than those in KitW-sh/W-sh mast cell-deficient AD mice, with IL-4 levels of (29.50±1.87) and (15.33±1.86) pg/mg (P<0.001), IL-13 levels were (6.32±0.25) and (3.93±0.22) pg/mg (P<0.001), IL-31 levels were (9.73±0.38) and (6.89±0.27) pg/mg (P<0.001), and TSLP levels were (206.00±4.43) and (99.00±4.86) pg/mg (P<0.001), respectively. MC903 could cause mast cell activation in wild-type mice, leading to increased swelling and exudation in the toes of mice, and MC903 could activate mast cells in vitro, leading to increased degranulation and release of inflammatory factors such as MCP-1 and CXCL-2. Conclusions: The number of activated mast cells was increased in skin lesions of AD patients than in healthy controls. KitW-sh/W-sh mast cell-deficient AD mice showed significantly reduced phenotype, histopathology, and type 2 inflammatory factor levels compared with wild-type AD mice. MC903 activates mast cells in vivo and in vitro. Mast cells play a key role in AD phenotype and immune activation.

Role of Staphylococcus Aureus Enterotoxin B in Activation of LAD2 Mast Cells

Role of mast cells in Staphylococcus aureus enterotoxin B-induced atopic dermatitis-like skin inflammation in mice

Staphylococcus Aureus Enterotoxin B is a Cofactor of Food Allergy Beyond a Superantigen.

Role of Acid Sphingomyelinase in the Regulation of Mast Cell Function

A Higher Dose of Staphylococcus Aureus Enterotoxin B Led to More Th1 and Lower Th2/Th1 Ratio in Th Cells.

Expression and Bioactivity Analysis of Staphylococcal Enterotoxin M and N

Possible Role of Staphylococcal Enterotoxin B in the Pathogenesis of Autoimmune Diseases

Lidocaine inhibits staphylococcal enterotoxin-stimulated activation of peripheral blood mononuclear cells from patients with atopic dermatitis

Effects and mechanism of anaphylactoid reaction induced by nonapeptide activating mast cells

Construction of Prokaryotic Expression System of Staphylococcal Enterotoxin B Gene and Effects of Its Expressed Product on Promoting Lymphocyte Proliferation and Inhibiting the Growth of Tumor Cell

Structural Basis For The Neutralization And Specificity Of Staphylococcal Enterotoxin B Against Its Mhc Class Ii Binding Site

Prokaryotic Expression,Purification and Identification of the Biological Effects of Staphylococcal Enterotoxin B

Binding of Staphylococcal Enterotoxin B (SEB) to B7 Receptors Triggers TCR- and CD28-Mediated Inflammatory Signals in the Absence of MHC Class II Molecules

The effector cells activated by superantigen SEB leading to tolerance rather than cytokines

The role of activated adenosine receptors in degranulation of human LAD2 mast cells.

Exposure to aerosolized staphylococcal enterotoxin B potentiated by lipopolysaccharide modifies lung transcriptomes and results in lung injury in the mouse model

Attenuation of massive cytokine response to the staphylococcal enterotoxin B superantigen by the innate immunomodulatory protein lactoferrin

Sulfur Dioxide Inhibits Mast Cell Degranulation by Sulphenylation of Galectin-9 at Cysteine 74

Effects of Dendritic Cells Induced by Superantigen Staphylococcal Enterotoxin B or Staphylococcal Enterotoxin C on T Lymphocytes

[Preliminary Studies on the Role of Mast Cells in the Phenotype and Immune Activation of Type 2 Inflammatory Cytokine Release of Atopic Dermatitis].

Sereening and characterization of neutralizing monoclonal antibodies against Staphylococcal enterotoxin B